Condition
Lymphocele After Surgical Procedure
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
80.0%-7% vs avg
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
80.0%
-6.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results80% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 4 (1)
Trial Status
Completed4
Terminated1
Trial Success Rate
80.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06284135Not ApplicableCompletedPrimary
MICHL-trial: Impact of Peritoneal Bladder Flap in RARP Patients on Lymphoceles
NCT04853095Not ApplicableCompleted
Effect of Peritoneal Fixation on Lymphocele Formation
NCT03567525Not ApplicableCompletedPrimary
Peritoneal Iliac Flap and Lymphocele Formation After Robotic Radical Prostatectomy
NCT03006562Phase 4Terminated
PREvention of VENous ThromboEmbolism Following Radical Prostatectomy
NCT04205864Not ApplicableCompleted
Application of Thrombin Gel Matrix for the Prevention of Lymphocele in Patients With Endometrial Cancer.
Showing all 5 trials